FDA Adverse Event Injury Summary report: N

MYNX VASCULAR CLOSURE DEVICE

MDR report key: 1013953 · Received March 14, 2008

Report

Report Number
3004939290-2008-00016
Event Type
Injury
Date Received
March 14, 2008
Date of Event
February 26, 2008
Report Date
March 14, 2008
Manufacturer
ACCESSCLOSURE, INC.
Product Code
MGB
PMA / PMN Number
P040044
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION, AND THE LOT NUMBER WAS NOT PROVIDED FOR LOT HISTORY REVIEW. BASED ON THE INFORMATION PROVIDED AND THE INVESTIGATION PERFORMED, THE ROOT CAUSE OF THE REPORTED INCIDENT COULD NOT BE DETERMINED. NO OTHER INFORMATION, INDICATING THAT THE DEVICE DID NOT PERFORM AS INTENDED, HAS BEEN PROVIDED. THE EXCISED MATERIAL WAS NOT SENT TO PATHOLOGY. THEREFORE THE IDENTIFICATION OF THE MATERIAL IS UNDETERMINED.

Description of Event or Problem · 1

A FEMALE PATIENT REPORTEDLY UNDERWENT AN UNCOMPLICATED CORONARY INTERVENTION IN 2008. THE PHYSICIAN, TRAINED TO THE MYNX PROCEDURE, REPORTEDLY USED THE MYNX DEVICE PER IFU, AND HEMOSTASIS WAS ACHIEVED WITHOUT COMPLICATION. THE PATIENT RETURNED TO THE HOSPITAL ON TEN DAYS LATER, FOR REPEAT CATHETERIZATION DUE TO CONTINUED CHEST PAIN. FEMORAL ANGIOGRAM WAS ASSESSED PRIOR TO CLOSURE WHICH DEMONSTRATED A MOBILE LUCENCY IN THE AREA OF THE PREVIOUS MYNX SITE. THE PATIENT WAS ASYMPTOMATIC, HOWEVER, THE PHYSICIAN RECOMMENDED EXPLORATION AND EXTRACTION DUE TO THE POTENTIAL RISK OF FUTURE EMBOLIZATION AND ISCHEMIA. DURING THE SURGICAL PROCEDURE, THE CURRENT SHEATH WAS REMOVED AS WELL AS THE REPORTED ABNORMALITY SEEN ON THE ANGIO. THE PROCEDURE LASTED APPROXIMATELY 25 MINUTES AND WAS REPORTEDLY PERFORMED WITHOUT COMPLICATION. THE PATIENT WAS DISCHARGED THE NEXT DAY, WITHOUT FURTHER INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MYNX VASCULAR CLOSURE DEVICE MYNX VASCULAR CLOSURE DEVICE MGB ACCESSCLOSURE, INC. MX6700 UNK

Patients

Seq Age Sex Outcome Treatment
1 56 YR Required Intervention MEDICATIONS INCLUDED PLAVIX| COUMADIN.